000 | 01113 a2200313 4500 | ||
---|---|---|---|
005 | 20250513040323.0 | ||
264 | 0 | _c19930707 | |
008 | 199307s 0 0 eng d | ||
022 | _a0143-4004 | ||
024 | 7 |
_a10.1016/s0143-4004(05)80259-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLyden, T W | |
245 | 0 | 0 |
_aModulation of phosphatidylserine epitope expression by BeWo cells during forskolin treatment. _h[electronic resource] |
260 |
_bPlacenta _c |
||
300 |
_a177-86 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAntigenic Modulation _xdrug effects |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aChoriocarcinoma _ximmunology |
650 | 0 | 4 |
_aColforsin _xpharmacology |
650 | 0 | 4 |
_aEpitopes _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPhosphatidylserines _ximmunology |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aNg, A K | |
700 | 1 | _aRote, N S | |
773 | 0 |
_tPlacenta _gvol. 14 _gno. 2 _gp. 177-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0143-4004(05)80259-0 _zAvailable from publisher's website |
999 |
_c7684521 _d7684521 |